Faculty

R. Scott McClelland

Professor, Epidemiology
Professor, Medicine - Allergy and Infectious Dis.
Professor, Global Health

206-543-4278

Education

MD Medicine, University of Washington, 1995
MPH Epidemiology, University of Washington, 2001
BS Biology, University of Washington, 1989

Contact

206-543-4278

University of Washington
Box 359909
325 9th Avenue
Seattle, WA 98104

Bio

Dr. McClelland is a Professor of Epidemiology, Medicine, and Global Health. He leads a trainee-driven research program linking Seattle and Kenya in collaboration with the Fred Hutchinson Cancer Research Center and the University of Nairobi (UON). Dr. McClelland's research spans a range of topics in HIV, STIs, women's health, key populations epidemiology, clinical trials, and implementation research.

Research Interests

  • Impact of periconceptual vaginal microbiota on women's risk of preterm birth 
  • Randomized trial of an implementation science tool to integrate HIV testing into family planning services in Mombasa County, Kenya 
  • Motivation matters! Randomized trial of theory-based, SMS to support treatment as prevention in high-risk women 
  • Development of a point of care cervical cancer diagnostic platform for low-resource settings 
  • Validation of collection Methods for high risk HPV Detection 
  • Women's life course events & HIV transmission potential: A multidisciplinary study

Recent Publications (PubMed)

HIV incidence among women engaging in sex work in sub-Saharan Africa: a systematic review and meta-analysis.
(2024 Aug)
Lancet Glob Health 12(8): e1244-e1260
Jones HS, Anderson RL, Cust H, McClelland RS, Richardson BA, Thirumurthy H, Malama K, Hensen B, Platt L, Rice B, Cowan FM, Imai-Eaton JW, Hargreaves JR, Stevens O
A prospective cohort study examining the association between the periconceptual vaginal microbiota and first-trimester miscarriage in Kenyan women.
(2024 Jul 1)
Paediatr Perinat Epidemiol
McClelland RS, Lokken EM, Kinuthia J, Srinivasan S, Richardson BA, Jaoko W, Lannon S, Pulei A, Fiedler TL, Munch MM, Proll S, John-Stewart G, Fredricks DN
Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine.
(2024 Feb)
Open Forum Infect Dis 11(2): ofad673
Babu TM, Shen X, McClelland RS, Wang Z, Selke S, Wilkens C, Hauge KA, McClurkan CL, Goecker E, Laing KJ, Koelle DM, Greninger AL, Nussenzweig MC, Montefiori DC, Corey L, Wald A
AMCP Market Insights Health Plan Best Practice: Implementing continuous glucose monitoring to improve patient outcomes in diabetes.
(2024 Jan)
J Manag Care Spec Pharm 30(1-a Suppl): S1-S15
Pangrace M, Dolan S, Grace T, Greene E, Long E, McClelland S, Moore J, Morgan DE, Mullins H, Wescott S
Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in Women.
(2023 Dec 21)
N Engl J Med 389(25): 2331-2340
Stewart J, Oware K, Donnell D, Violette LR, Odoyo J, Soge OO, Scoville CW, Omollo V, Mogaka FO, Sesay FA, McClelland RS, Spinelli M, Gandhi M, Bukusi EA, Baeten JM, dPEP Kenya Study Team
Show complete publication list